BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fu Y, Xiao W, Mao Y. Recent Advances and Challenges in Uveal Melanoma Immunotherapy. Cancers 2022;14:3094. [DOI: 10.3390/cancers14133094] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Prendergast CM, Capaccione KM, Lopci E, Das JP, Shoushtari AN, Yeh R, Amin D, Dercle L, De Jong D. More than Just Skin-Deep: A Review of Imaging's Role in Guiding CAR T-Cell Therapy for Advanced Melanoma. Diagnostics (Basel) 2023;13. [PMID: 36900136 DOI: 10.3390/diagnostics13050992] [Reference Citation Analysis]
2 Tao YX, Li HW, Luo JT, Li Y, Wei WB. Regional chemotherapy for uveal melanoma liver metastases. Int J Ophthalmol 2023;16:293-300. [PMID: 36816216 DOI: 10.18240/ijo.2023.02.18] [Reference Citation Analysis]
3 Menon AP, Moreno B, Meraviglia-Crivelli D, Nonatelli F, Villanueva H, Barainka M, Zheleva A, van Santen HM, Pastor F. Modulating T Cell Responses by Targeting CD3. Cancers (Basel) 2023;15. [PMID: 36831533 DOI: 10.3390/cancers15041189] [Reference Citation Analysis]
4 Zhu R, Chen YT, Wang BW, You YY, Wang XH, Xie HT, Jiang FG, Zhang MC. TAP1, a potential immune-related prognosis biomarker with functional significance in uveal melanoma. BMC Cancer 2023;23:146. [PMID: 36774490 DOI: 10.1186/s12885-023-10527-9] [Reference Citation Analysis]
5 Zhang F, Deng Y, Wang D, Wang S. Construction and Verification of the Molecular Subtype and a Novel Prognostic Signature Based on Inflammatory Response-Related Genes in Uveal Melanoma. J Clin Med 2023;12. [PMID: 36769510 DOI: 10.3390/jcm12030861] [Reference Citation Analysis]
6 Thariat J, Boudin L, Loria O, Nguyen AM, Kodjikian L, Mathis T. How to Manage a Patient with Ocular Metastases? Biomedicines 2022;10. [PMID: 36551800 DOI: 10.3390/biomedicines10123044] [Reference Citation Analysis]
7 Hu Y, Cai J, Ye M, Mou Q, Zhao B, Sun Q, Lou X, Zhang H, Zhao Y. Development and validation of immunogenic cell death-related signature for predicting the prognosis and immune landscape of uveal melanoma. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1037128] [Reference Citation Analysis]
8 Wei X, Yang H, Fu Z, Yin X, Xiong W. ncRNAs-mediated high expression of CDCA7L favors the prognosis of uveal melanoma and is associated with an immune checkpoint PD1.. [DOI: 10.21203/rs.3.rs-2014218/v1] [Reference Citation Analysis]